Search Results | Diabetes Care | American Diabetes Association

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort

Vanita R. Aroda, Heidi Krause-Steinrauf, Erin J. Kazemi, John B. Buse, Barbara I. Gulanski, Hermes J. Florez, Andrew J. Ahmann, Amy Loveland, Alexander Kuhn, Jacqueline Y. Lonier, Deborah J. Wexler, the GRADE Research Group

Diabetes Care 2022;45(7):1512–1521

DOI: https://doi.org/10.2337/dc21-2659

Published: 06 July 2022

View article

Journal Articles

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew J. Ahmann, Matthew Capehorn, Guillaume Charpentier, Francesco Dotta, Elena Henkel, Ildiko Lingvay, Anders G. Holst, Miriam P. Annett, Vanita R. Aroda

Diabetes Care 2018;41(2):258–266

DOI: https://doi.org/10.2337/dc17-0417

Published: 15 December 2017

View article

Includes: Supplementary data

Journal Articles

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Diabetes Care 2017;40(4):538–545

DOI: https://doi.org/10.2337/dc16-2482

Published: 16 February 2017

View article

Includes: Supplementary data

Journal Articles

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Richard M. Bergenstal, Timothy S. Bailey, David Rodbard, Monika Ziemen, Hailing Guo, Isabel Muehlen-Bartmer, Andrew J. Ahmann

Diabetes Care 2017;40(4):554–560

DOI: https://doi.org/10.2337/dc16-0684

Published: 23 January 2017

View article

Includes: Supplementary data

Journal Articles

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck

Diabetes Care 2016;39(10):e193–e194

DOI: https://doi.org/10.2337/dci16-0025

Published: 13 September 2016

View article

Journal Articles

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

Diabetes Care 2016;39(4):603–610

DOI: https://doi.org/10.2337/dc15-1426

Published: 17 December 2015

View article

Includes: Supplementary data

Journal Articles

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Diabetes Care 2016;39(2):264–270

DOI: https://doi.org/10.2337/dc15-1498

Published: 17 December 2015

View article

Includes: Supplementary data

Journal Articles

Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702–2709

Jenise C. Wong, Nicole C. Foster, David M. Maahs, Dan Raghinaru, Richard M. Bergenstal, Andrew J. Ahmann, Anne L. Peters, Bruce W. Bode, Grazia Aleppo, Irl B. Hirsch, Lora Kleis, H. Peter Chase, Stephanie N. DuBose, Kellee M. Miller, Roy W. Beck, Saleh Adi

Diabetes Care 2015;38(4):e61

DOI: https://doi.org/10.2337/dc14-2782

Published: 14 March 2015

View article

Journal Articles

Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

Asa K. Davis, Stephanie N. DuBose, Michael J. Haller, Kellee M. Miller, Linda A. DiMeglio, Kathleen E. Bethin, Robin S. Goland, Ellen M. Greenberg, David R. Liljenquist, Andrew J. Ahmann, Santica M. Marcovina, Anne L. Peters, Roy W. Beck, Carla J. Greenbaum

Diabetes Care 2015;38(3):476–481

DOI: https://doi.org/10.2337/dc14-1952

Published: 17 December 2014

View article

Includes: Supplementary data

Journal Articles

Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry

Diabetes Care 2014;37(10):2702–2709

DOI: https://doi.org/10.2337/dc14-0303

Published: 10 September 2014

View article

Includes: Supplementary data

Journal Articles

Can Trained Dogs Detect a Hypoglycemic Scent in Patients With Type 1 Diabetes?

Ky Dehlinger, DVM, Kristin Tarnowski, BS, MED, Jody L. House, SCD, Evan Los, MD, Kathryn Hanavan, RN, Bryan Bustamante, BS, Andrew J. Ahmann, MD, W. Kenneth Ward, MD

Diabetes Care 2013;36(7):e98–e99

DOI: https://doi.org/10.2337/dc12-2342

Published: 12 June 2013

View article

Journal Articles

Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

Julio Rosenstock, MD, Andrew J. Ahmann, MD, Gildred Colon, MD, Jamie Scism-Bacon, PHD, Honghua Jiang, PHD, Sherry Martin, MD

Diabetes Care 2008;31(1):20–25

DOI: https://doi.org/10.2337/dc07-1122

Published: 01 January 2008

View article

Includes: Supplementary data

Journal Articles

Ultradian Variation of Blood Glucose in Intensive Care Unit Patients Receiving Insulin Infusions

Stephen M. Smith, FJFICM, PHD, Kelsey E. Oveson, BA, Wayne Strauss, MD, PHD, Kathryn Raven, RN, MSN, Mary C. Lefevre, PHARMD, Andrew J. Ahmann, MD, Daniel S. Hagg, MD

Diabetes Care 2007;30(10):2503–2505

DOI: https://doi.org/10.2337/dc07-0865

Published: 01 October 2007

View article

Includes: Supplementary data

NARROW

Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702–2709

Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry

Can Trained Dogs Detect a Hypoglycemic Scent in Patients With Type 1 Diabetes?

Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

Ultradian Variation of Blood Glucose in Intensive Care Unit Patients Receiving Insulin Infusions

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only